Arrowstreet Capital, Limited Partnership Kamada LTD Transaction History

Arrowstreet Capital, Limited Partnership

  • $121 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$4.56 - $7.13 $182,103 - $284,736
-39,935 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$4.97 - $7.7 $198,476 - $307,499
39,935 New
39,935 $274,000
Q2 2019

Aug 14, 2019
SELL
$5.39 - $6.26 $164,174 - $190,673
-30,459 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$5.12 - $6.18 $9,021 - $10,889
1,762 Added 6.14%
30,459 $175,000
Q4 2018

Feb 14, 2019
BUY
$4.68 - $6.25 $134,301 - $179,356
28,697 New
28,697 $143,000

Others Institutions Holding KMDA

# of Institutions
33
Shares Held
6.48M
Call Options Held
200
Put Options Held
0
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $271M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email